Cargando…

Survival Analysis of Hepatocellular Carcinoma: A Comparison Between Young Patients and Aged Patients

BACKGROUND: To compare the clinicopathological features and prognosis between younger and aged patients with hepatocellular carcinoma (HCC). METHODS: We analyzed the outcome of 451 HCC patients underwent liver resection, transcatheter arterial chemoembolization and radiofrequency ablation, respectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xin-Sen, Chen, Wei, Miao, Run-Chen, Zhou, Yan-Yan, Wang, Zhi-Xin, Zhang, Ling-Qiang, Qu, Kai, Pang, Qing, Wang, Rui-Tao, Liu, Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733704/ https://www.ncbi.nlm.nih.gov/pubmed/26112722 http://dx.doi.org/10.4103/0366-6999.159356

Ejemplares similares

Simple models based on gamma-glutamyl transpeptidase and platelets for predicting survival in hepatitis B-associated hepatocellular carcinoma
por: Pang, Qing, et al.
Publicado: (2016)

Comparison of survival between adolescent and young adult vs older patients with hepatocellular carcinoma
por: Ren, Jie, et al.
Publicado: (2020)

Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma
por: Deng, Yan, et al.
Publicado: (2016)

Seven-senescence-associated gene signature predicts overall survival for Asian patients with hepatocellular carcinoma
por: Xiang, Xiao-Hong, et al.
Publicado: (2019)

Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma
por: Gu, Jing-Xian, et al.
Publicado: (2019)

Evaluation of Eight Different Clinical Staging Systems Associated with Overall Survival of Chinese Patients with Hepatocellular Carcinoma
por: Zhao, Jian-Jun, et al.
Publicado: (2015)

Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation
por: Wang, Kang, et al.
Publicado: (2023)

Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma
por: Cai, Mu-Yan, et al.
Publicado: (2016)

Deep learning-based radiomics based on contrast-enhanced ultrasound predicts early recurrence and survival outcome in hepatocellular carcinoma
por: Huang, Zhe, et al.
Publicado: (2022)

Novel candidate biomarkers of origin recognition complex 1, 5 and 6 for survival surveillance in patients with hepatocellular carcinoma
por: Wang, Xiang-Kun, et al.
Publicado: (2020)

Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II
por: Lv, Jia-Yu, et al.
Publicado: (2021)

Low GAS5 Levels as a Predictor of Poor Survival in Patients with Lower-Grade Gliomas
por: Wang, Yanfang, et al.
Publicado: (2019)

Effect of timing of surgical resection of primary hepatocellular carcinoma on survival outcomes in elderly patients and prediction of clinical models
por: He, Yongfei, et al.
Publicado: (2021)

CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway
por: Cheng, Rui, et al.
Publicado: (2020)

Impact of marital status on overall survival in patients with early-stage hepatocellular carcinoma
por: Chen, Fangjie, et al.
Publicado: (2022)

Comprehensive analysis of an autophagy-related prognostic model for predicting survival based on TCGA and ICGC database in hepatocellular carcinoma patients
por: An, Li-Na, et al.
Publicado: (2022)

Intraoperative low-dose dopamine is associated with worse survival in patients with hepatocellular carcinoma: A propensity score matching analysis
por: Wang, Yan, et al.
Publicado: (2022)

Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients
por: Zhou, Zhong‐Guo, et al.
Publicado: (2020)

Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus
por: Yu, Tian-Zhu, et al.
Publicado: (2017)

ABO blood type correlates with survival in hepatocellular carcinoma following hepatectomy
por: Wu, Tao, et al.
Publicado: (2017)

Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma
por: Zhong, Jian-Hong, et al.
Publicado: (2015)

Effects and related mechanisms of serotonin on malignant biological behavior of hepatocellular carcinoma via regulation of Yap
por: Liu, Sushun, et al.
Publicado: (2017)

Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2019)

Outcomes of adolescent and young patients with hepatocellular carcinoma after curative liver resection: a retrospective study
por: Zhang, Zheng-Yun, et al.
Publicado: (2022)

Impact of overweightness and critical weight loss on overall survival in patients with hepatocellular carcinoma initially treated with chemoembolization
por: Chen, Zhen-Xin, et al.
Publicado: (2019)

Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib
por: Zhang, Lei, et al.
Publicado: (2020)

Decreased Expression of PTPN12 Correlates with Tumor Recurrence and Poor Survival of Patients with Hepatocellular Carcinoma
por: Luo, Rong-Zhen, et al.
Publicado: (2014)

A novel prognostic model predicting the long-term cancer-specific survival for patients with hypopharyngeal squamous cell carcinoma
por: Tang, Xin, et al.
Publicado: (2020)

A nomogram combining PPARγ expression profiles and clinical factors predicts survival in patients with hepatocellular carcinoma
por: Zhou, Xiaolu, et al.
Publicado: (2021)

Combination of Tertiary Lymphoid Structure and Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients With Hepatocellular Carcinoma
por: Wen, Shaodi, et al.
Publicado: (2022)

Association Between Body Mass Index and Survival Outcomes In Patients Treated With Immune Checkpoint Inhibitors: Meta-analyses of Individual Patient Data
por: Nie, Run-Cong, et al.
Publicado: (2021)

Comparison of 10 noninvasive models for predicting overall survival in patients with intermediate-stage hepatocellular carcinoma
por: Hsu, Wei-Fan, et al.
Publicado: (2021)

Head-to-head comparison of Sonazoid and SonoVue in the diagnosis of hepatocellular carcinoma for patients at high risk
por: Huang, Jiayan, et al.
Publicado: (2023)

RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival
por: Dong, Zhao-Ru, et al.
Publicado: (2021)

Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma
por: Yin, Xin, et al.
Publicado: (2014)

Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKI
por: Liu, Yu-Tao, et al.
Publicado: (2019)

Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus
por: Zhang, Zi-Han, et al.
Publicado: (2017)

Prognostic nomogram for hepatocellular carcinoma in adolescent and young adult patients after hepatectomy
por: Zhang, Wei, et al.
Publicado: (2017)

Modeling Sarcopenia to Predict Survival for Patients With Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy
por: Hua, Xin, et al.
Publicado: (2021)

Preoperative Pectoralis Muscle Index Predicts Distant Metastasis-Free Survival in Breast Cancer Patients
por: Huang, Wen-juan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t25u83efq9lnddmj3r43q9b8op